About Pharsight
Pharsight is a company based in Mountain View (United States) founded in 1995 was acquired by Tripos International in September 2008. Pharsight has raised $7.5 million across 2 funding rounds from investors including Credit Suisse, Alloy Ventures and Tripos International. Pharsight offers products and services including Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™. Pharsight operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
- Headquarter Mountain View, United States
- Stage Public
- SectorsHealthcare
- Website pharsight.com
- Social LinkedIn X
- Acquired by Tripos International (Sep 2008)
- Total Equity Funding$7.5M (USD)
in 2 rounds
- Latest Funding Round$4.4M (USD), Private Equity Round
Sep 2002
- InvestorsCredit Suisse
& 2 more
- Acquired byTripos International
(Sep 2008)
Products & Services of Pharsight
Pharsight offers a comprehensive portfolio of products and services, including Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™.
Tool for PK, PD, and toxicokinetic analysis in drug development.
Platform for data standardization and validation in clinical trials.
System for predicting drug behavior in diverse populations.
System for publishing and transmitting regulatory submissions.
Funding Insights of Pharsight
Pharsight has successfully raised a total of $7.5M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $4.4 million completed in September 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.5M
- Total Rounds 2
- Last Round Private Equity Round — $4.4M
- First Round $3.1M
(Jun 2002)
- Investors Count 2
All 2 funding rounds of Pharsight with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2002 | $4.4M | Private Equity Round | – | – | |
| Jun 2002 | $3.1M | Private Equity Round | – | – |
3 investors in total: 3 institutional.
Investors in Pharsight
Pharsight has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Alloy Ventures and Tripos International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage venture capital firm investing in the US | – | alloyventures.com | Palo Alto, United States | |
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland | |
Offers predictive simulation, modeling, and AI tools for pharmaceutical innovation. | 1988 | tripos.com | St. Louis, United States |
Investor details for Pharsight
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pharsight
5 dated milestones of Pharsight across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Pharsight is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $3.1M.
- Funding Latest funding round, Private Equity Round, of $4.4M.
- Exit Acquired by Tripos International.
Competitors of Pharsight
Pharsight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $255.15M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| fishawack.com | 2001 | Brighton, United Kingdom | $23.59M | 45 | Fully integrated cross-border services are delivered to global pharmaceutical organizations. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| fabtechnologies.com | 2002 | Mumbai, India | $175,048 | 279 | Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. |
Detailed competitors of Pharsight
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pharsight
Websites that share an audience with Pharsight (pharsight.com).
Websites whose visitors overlap most with Pharsight. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| certara.com | 100% | 98.2K | #495,649 | View details |
Similar companies to Pharsight
10 companies that operate in the same segment as Pharsight (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharsight
Pharsight was founded in 1995 and raised its 1st funding round 7 years after it was founded.
Pharsight is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Pharsight is a funded company, having raised a total of $7.5M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $3.1M, raised on Jun 2002.
Pharsight was founded in 1995 in Mountain View, United States, focusing on the pharmaceutical sector. Software tools for drug modeling, clinical pharmacology, trial design, dose optimization, and data management are developed. Scientific consulting services, including quantitative analysis and predictive models for diseases, drugs, and clinical trials, are provided to aid decision-making and regulatory submissions. The company was taken public in 2000 and later acquired by Tripos International.
Pharsight's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Pharsight offers Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™.
Pharsight has 3 investors. Key investors include Credit Suisse, Alloy Ventures, and Tripos International.
Yes. Pharsight was acquired by Tripos International in September 2008.